{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:04:01Z","timestamp":1775495041709,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.arcped.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T01:26:12Z","timestamp":1460683572000},"page":"957-962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neonatal transient hypophosphatemic hypercalciuric rickets in dizygous twins: A role for maternal alendronate therapy before pregnancy or antireflux medications?"],"prefix":"10.1016","volume":"23","author":[{"given":"M.","family":"Gerin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Jambon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fouque-Aubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Raybaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cochat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Claris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2016.03.001_bib0080","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00198-009-0983-1","article-title":"Maternal and fetal outcome after long-term bisphosphonate exposure before conception","volume":"21","author":"Hassen-Zrour","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.arcped.2016.03.001_bib0085","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bone.2011.06.027","article-title":"Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover","volume":"49","author":"Peris","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.arcped.2016.03.001_bib0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.earlhumdev.2010.02.007","article-title":"Prolonged maternal magnesium administration and bone metabolism in neonates","volume":"86","author":"Yokoyama","year":"2010","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.arcped.2016.03.001_bib0095","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/00003088-200544060-00001","article-title":"Pharmacokinetics\/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis","volume":"44","author":"Cremers","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.arcped.2016.03.001_bib0100","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1997.12.10.1700","article-title":"Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis","volume":"12","author":"Khan","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.arcped.2016.03.001_bib0105","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.arcped.2016.03.001_bib0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.autrev.2010.03.002","article-title":"Bisphosphonates in patients with autoimmune rheumatic diseases: can they be used in women of childbearing age?","volume":"9","author":"Losada","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.arcped.2016.03.001_bib0115","first-page":"654","article-title":"Reproduction toxicity studies with pamidronate","volume":"42","author":"Graepel","year":"1992","journal-title":"Arzneimittel-Forschung"},{"key":"10.1016\/j.arcped.2016.03.001_bib0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H","article-title":"Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats","volume":"60","author":"Patlas","year":"1999","journal-title":"Teratology"},{"key":"10.1016\/j.arcped.2016.03.001_bib0125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.14310\/horm.2002.1319","article-title":"The use of bisphosphonates in women prior to or during pregnancy and lactation","volume":"10","author":"Stathopoulos","year":"2011","journal-title":"Hormones"},{"key":"10.1016\/j.arcped.2016.03.001_bib0130","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1359\/JBMR.040711","article-title":"Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases","volume":"19","author":"Munns","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.arcped.2016.03.001_bib0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1359\/jbmr.2000.15.3.557","article-title":"A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy","volume":"15","author":"Black","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.arcped.2016.03.001_bib0140","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1359\/jbmr.2000.15.10.2052","article-title":"Intravenous pamidronate for treatment of reflex sympathetic dystrophy during breast feeding","volume":"15","author":"Siminoski","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.arcped.2016.03.001_bib0145","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jpeds.2004.06.066","article-title":"Short-term safety assessment in the use of intravenous zoledronic acid in children","volume":"145","author":"Hogler","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2016.03.001_bib0150","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMc062792","article-title":"Prolonged bisphosphonate release after treatment in children","volume":"356","author":"Papapoulos","year":"2007","journal-title":"N Eng J Med"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X16300999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X16300999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T09:55:12Z","timestamp":1536832512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X16300999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0929693X16300999"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2016.03.001","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal transient hypophosphatemic hypercalciuric rickets in dizygous twins: A role for maternal alendronate therapy before pregnancy or antireflux medications?","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}